Economic Evaluation of Abiraterone in Metastatic Castration-Resistant Prostate Cancer in Patients With None/Mild Symptoms After Failure of Androgen Deprivation Therapy
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.270
https://www.valueinhealthjournal.com/article/S1098-3015(17)30604-6/fulltext
Title :
Economic Evaluation of Abiraterone in Metastatic Castration-Resistant Prostate Cancer in Patients With None/Mild Symptoms After Failure of Androgen Deprivation Therapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30604-6&doi=10.1016/j.jval.2017.08.270
First page :
A446
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
250